Wird geladen...
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition
The number of individuals who succumb to thyroid cancer has been increasing and those who are refractory to standard care have limited therapeutic options, highlighting the importance of developing new treatments for patients with aggressive forms of the disease. Mutational activation of MAPK signal...
Gespeichert in:
| Veröffentlicht in: | Endocr Relat Cancer |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7062234/ https://ncbi.nlm.nih.gov/pubmed/31146260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0188 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|